← Back to Search

Behavioural Intervention

Intervention group for Infections (IRIS Trial)

N/A

Waitlist Available

Research Sponsored by McMaster University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Presenting with a confirmed or suspected injection-related infection (including skin and soft tissue infections, osteomyelitis, infective endocarditis, Hepatitis C, HIV, etc)

Age 16 or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 6-months of hospital discharge or program enrolment

Awards & highlights

IRIS Trial Summary

This trial provides a 1-stop shop of care, support & systems navigation for people who inject drugs & experience injection-related infections. It aims to improve access to treatment & reduce ED visits, hospitalizations & deaths.

Who is the study for?

The IRIS program is for individuals in Hamilton, Ontario who use injection drugs and have an infection related to this, like abscesses or heart valve infections. Participants must be 16 or older and able to give informed consent.Check my eligibility

What is being tested?

This trial tests a holistic care approach for people with drug-related infections. It provides substance use treatment, infectious disease care, peer support, and help navigating the system without randomizing participants.See study design

What are the potential side effects?

Since this is not a drug trial but rather a service intervention study, traditional side effects are not applicable. However, there may be emotional or social impacts from participating in such comprehensive care programs.

IRIS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have or might have an infection from an injection, including skin, bone, heart infections, Hepatitis C, or HIV.

Select...

I am 16 years old or older.

IRIS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 6-months of hospital discharge or program enrolment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 6-months of hospital discharge or program enrolment

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 6-months of hospital discharge or program enrolment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of emergency department visits and hospital readmission

Secondary outcome measures

Completion of intended course of treatment for the injection-related infection

Mortality rates

Number of emergency department visits

+3 more

IRIS Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention groupExperimental Treatment1 Intervention

Participants in the IRIS program will be offered a one-stop, low-barrier combined care model to address their injection-related infections. Specific program components include: (1) Diagnosis and treatment of injection-related infections; (2) Substance use treatment (3) Peer support; and (4) Care coordination/systems navigation.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Keeping SixUNKNOWN

YWCA HamiltonUNKNOWN

McMaster UniversityLead Sponsor

886 Previous Clinical Trials

2,598,392 Total Patients Enrolled

15 Trials studying Infections

30,723 Patients Enrolled for Infections

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is granted access to participate in this medical study?

"This trial is recruiting 80 individuals with infection and who meet the age criteria of 16 to 105 years old."

Answered by AI

Does this experimental trial accommodate adults of advanced age?

"This clinical study seeks participants between the ages of 16 and 105. There are 197 trials available for underage people, while seniors can enroll in 620 different studies."

Answered by AI

Are individuals still able to enroll in this research effort?

"As reported on clinicaltrials.gov, this research is not currently enrolling patients. It was originally posted in January of 2024 and last modified December 5th 2023; however, there are presently 782 other trials actively seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Injection-Related InfectionS (IRIS) Program

2024. "The Injection-Related InfectionS (IRIS) Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06169553.

All > Infectious Disease